Steven Cohen Bridge Bio Pharma, Inc. Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 60,000 shares of BBIO stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,000
Previous 35,000
71.43%
Holding current value
$2.09 Million
Previous $891,000
84.74%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
315Shares Held
177MCall Options Held
11.2MPut Options Held
2.29M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$882 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$877 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$526 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$434 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$216 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.17B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...